Reinhart Partners Inc. Raises Stock Position in Medical Properties Trust, Inc. (NYSE:MPW)

Reinhart Partners Inc. boosted its holdings in Medical Properties Trust, Inc. (NYSE:MPW) by 0.5% in the third quarter, HoldingsChannel reports. The institutional investor owned 194,302 shares of the real estate investment trust’s stock after purchasing an additional 910 shares during the quarter. Reinhart Partners Inc.’s holdings in Medical Properties Trust were worth $3,801,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Lenox Wealth Advisors LLC purchased a new stake in Medical Properties Trust in the 3rd quarter worth $31,000. Cullen Frost Bankers Inc. increased its stake in Medical Properties Trust by 70.9% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock worth $32,000 after buying an additional 760 shares in the last quarter. Manchester Financial Inc. purchased a new stake in Medical Properties Trust in the 2nd quarter worth $33,000. Cascade Investment Advisors Inc. purchased a new stake in Medical Properties Trust in the 2nd quarter worth $35,000. Finally, Private Ocean LLC purchased a new stake in Medical Properties Trust in the 3rd quarter worth $50,000. Institutional investors and hedge funds own 71.66% of the company’s stock.

A number of brokerages have recently weighed in on MPW. SunTrust Banks raised their price objective on Medical Properties Trust from $20.00 to $21.00 and gave the company a “buy” rating in a research report on Tuesday, August 27th. Barclays set a $22.00 price objective on Medical Properties Trust and gave the company a “buy” rating in a research report on Monday, October 21st. ValuEngine lowered Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Tuesday, November 5th. Zacks Investment Research upgraded Medical Properties Trust from a “hold” rating to a “buy” rating and set a $22.00 price objective for the company in a research report on Wednesday, October 16th. Finally, Bank of America began coverage on Medical Properties Trust in a research report on Monday, October 14th. They set a “neutral” rating and a $19.50 price objective for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $20.18.

In related news, CEO Edward K. Aldag, Jr. sold 101,964 shares of Medical Properties Trust stock in a transaction dated Thursday, October 10th. The stock was sold at an average price of $19.78, for a total value of $2,016,847.92. Following the completion of the transaction, the chief executive officer now owns 2,058,820 shares in the company, valued at $40,723,459.60. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Emmett E. Mclean sold 100,000 shares of Medical Properties Trust stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $18.37, for a total value of $1,837,000.00. Following the completion of the transaction, the insider now owns 1,066,337 shares of the company’s stock, valued at approximately $19,588,610.69. The disclosure for this sale can be found here. In the last quarter, insiders sold 279,464 shares of company stock valued at $5,359,673. 1.18% of the stock is currently owned by company insiders.

Shares of Medical Properties Trust stock traded up $0.53 during trading on Friday, reaching $19.95. 16,826,344 shares of the stock traded hands, compared to its average volume of 4,039,835. The company has a market capitalization of $8.56 billion, a price-to-earnings ratio of 14.56, a P/E/G ratio of 3.39 and a beta of 0.52. The business has a fifty day simple moving average of $19.84 and a two-hundred day simple moving average of $18.53. The company has a debt-to-equity ratio of 1.02, a current ratio of 6.27 and a quick ratio of 8.00. Medical Properties Trust, Inc. has a 52-week low of $15.25 and a 52-week high of $20.92.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.20 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.32 by ($0.12). The firm had revenue of $224.70 million for the quarter, compared to analysts’ expectations of $221.40 million. Medical Properties Trust had a net margin of 41.57% and a return on equity of 6.36%. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.35 EPS. On average, research analysts predict that Medical Properties Trust, Inc. will post 1.32 earnings per share for the current fiscal year.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

See Also: What factors cause inflation to rise?

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.